Veristat and Molecular Templates Inc. enter into Preferred Provider Agreement for Refractory non-Hodgkin’s B-Cell Lymphoma trial
For Immediate Release
Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.